Hope Works, the replacement for the now-defunct Downtown Streets Team, held a ribbon-cutting ceremony at its new office.
Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj). When ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results